Bank of New York Mellon Corp - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 52 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,730,411
+28.5%
118,051
+5.2%
0.00%0.0%
Q2 2023$2,902,356
+101.9%
112,190
+87.4%
0.00%
Q1 2023$1,437,765
+12.5%
59,857
-8.6%
0.00%
Q4 2022$1,277,485
+0.0%
65,512
+7.8%
0.00%
Q3 2022$1,277,000
-10.9%
60,775
-17.5%
0.00%
Q2 2022$1,433,000
+178.3%
73,647
+215.2%
0.00%
Q1 2022$515,000
+33.8%
23,368
-3.4%
0.00%
Q4 2021$385,000
-18.9%
24,194
+1.5%
0.00%
Q3 2021$475,000
+17.3%
23,844
+1.8%
0.00%
Q2 2021$405,000
-24.2%
23,428
-12.9%
0.00%
Q1 2021$534,000
+11.0%
26,907
-2.4%
0.00%
Q4 2020$481,000
+28.6%
27,570
+41.9%
0.00%
Q3 2020$374,000
-3.9%
19,428
-2.9%
0.00%
Q2 2020$389,000
+62.1%
20,003
+16.8%
0.00%
Q1 2020$240,000
-14.9%
17,128
+48.8%
0.00%
Q4 2019$282,00011,5080.00%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,621,118$38,939,25445.05%
NEA Management Company, LLC 4,186,243$100,553,5576.95%
Frazier Life Sciences Management, L.P. 3,860,107$92,719,7706.71%
Prosight Management, LP 567,826$13,639,1816.47%
TANG CAPITAL MANAGEMENT LLC 1,170,000$28,103,4004.19%
Highlander Partners, L.P. 122,980$2,953,9804.00%
Novo Holdings A/S 1,684,193$40,454,3162.67%
CADIAN CAPITAL MANAGEMENT, LP 734,922$17,652,8261.10%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,032,335$48,816,6871.09%
SILVERARC CAPITAL MANAGEMENT, LLC 105,939$2,544,6551.05%
View complete list of MIRUM PHARMACEUTICALS INC shareholders